Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study-Reference-Cited by-同舟云学术

Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study

Published:2018-03-27 Issue:1 Volume:18 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

He Le-Ye,Zhang Ming,Chen Zhi-Wen,Yuan Jian-Lin,Ye Ding-Wei,Ma Lu-Lin,Wei Hui,Yang Jiang-Gen,Chen Shan,Wan Ben,Xia Shu-Jie,Weng Zhi-Liang,Kong Xiang-Bo,Wei Qiang,Jin Feng-Shuo,Zhang Xiang-Hua,Qian Wei-Qing,Wang Shu-Sheng,Chen Ying-He,Ma Hong-Shun,Sun Ying-Hao,Gao Xu

Funder

Ipsen Fund

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12894-018-0337-4.pdf

Reference17 articles.

1. Ye D, Li C. Epidemiological trends of prostate cancer: retrospect and prospect. China Oncology. 2007;17:177–80.

2. Tao ZQ, Shi AM, Wang KX, Zhang WD. Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol sci. 2015;19:805–12.

3. Shore ND, Karsh L, Gomella LG, Keane TE, Concepcion RS, Crawford ED. Avoiding obsolescence in advanced prostate cancer management: a guide for urologists. BJU Int. 2015;115:188–97.